- Home
- TNGX vs SQFTP Comparison
TNGX vs SQFTP Comparison
Compare TNGX & SQFTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- SQFTP
- Stock Information
- Founded
- TNGX 2014
- SQFTP N/A
- Country
- TNGX United States
- SQFTP United States
- Employees
- TNGX N/A
- SQFTP 15
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- SQFTP Real Estate Investment Trusts
- Sector
- TNGX Health Care
- SQFTP Real Estate
- Exchange
- TNGX Nasdaq
- SQFTP Nasdaq
- Market Cap
- TNGX 351.2M
- SQFTP N/A
- IPO Year
- TNGX N/A
- SQFTP N/A
- Fundamental
- Price
- TNGX $5.02
- SQFTP $13.95
- Analyst Decision
- TNGX Strong Buy
- SQFTP
- Analyst Count
- TNGX 6
- SQFTP 0
- Target Price
- TNGX $12.20
- SQFTP N/A
- AVG Volume (30 Days)
- TNGX 4.0M
- SQFTP N/A
- Earning Date
- TNGX 08-06-2025
- SQFTP N/A
- Dividend Yield
- TNGX N/A
- SQFTP N/A
- EPS Growth
- TNGX N/A
- SQFTP N/A
- EPS
- TNGX N/A
- SQFTP N/A
- Revenue
- TNGX $40,990,000.00
- SQFTP N/A
- Revenue This Year
- TNGX N/A
- SQFTP N/A
- Revenue Next Year
- TNGX N/A
- SQFTP N/A
- P/E Ratio
- TNGX N/A
- SQFTP N/A
- Revenue Growth
- TNGX 10.09
- SQFTP N/A
- 52 Week Low
- TNGX $1.03
- SQFTP N/A
- 52 Week High
- TNGX $12.02
- SQFTP N/A
- Technical
- Relative Strength Index (RSI)
- TNGX 69.44
- SQFTP 54.10
- Support Level
- TNGX $4.70
- SQFTP $13.91
- Resistance Level
- TNGX $5.63
- SQFTP $14.05
- Average True Range (ATR)
- TNGX 0.60
- SQFTP 0.08
- MACD
- TNGX -0.01
- SQFTP 0.02
- Stochastic Oscillator
- TNGX 65.38
- SQFTP 93.94
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About SQFTP Presidio Property Trust Inc. 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock $0.01 par value per share
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.